Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video
Go back to Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.68 +0.03 (4.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.65 | 52 Week High | $9.58 | |||
| Open | $0.66 | 52 Week Low | $2.34 | |||
| Day High | $0.70 | P/E | N/A | |||
| Day Low | $0.64 | EPS | $-0.34 | |||
| Volume | 92,830 | |||||

